Cargando…
A Peptide-Fc Opsonin with Pan-Amyloid Reactivity
There is a continuing need for therapeutic interventions for patients with the protein misfolding disorders that result in systemic amyloidosis. Recently, specific antibodies have been employed to treat AL amyloidosis by opsonizing tissue amyloid deposits thereby inducing cell-mediated dissolution a...
Autores principales: | Foster, James S., Williams, Angela D., Macy, Sallie, Richey, Tina, Stuckey, Alan, Wooliver, Daniel Craig, Koul-Tiwari, Richa, Martin, Emily B., Kennel, Stephen J., Wall, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591422/ https://www.ncbi.nlm.nih.gov/pubmed/28928748 http://dx.doi.org/10.3389/fimmu.2017.01082 |
Ejemplares similares
-
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023) -
Evaluation of the effect of d-amino acid incorporation into amyloid-reactive peptides
por: Martin, Emily B., et al.
Publicado: (2017) -
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
por: Martin, Emily B., et al.
Publicado: (2023) -
A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo
por: Wall, Jonathan S., et al.
Publicado: (2013) -
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2015)